HomeDC4 • FRA
add
DexCom Inc
Nakaraang pagsara
€56.04
Sakop ng araw
€55.86 - €57.10
Sakop ng taon
€46.88 - €87.00
Market cap
25.54B USD
Average na Volume
183.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.21B | 21.64% |
Gastos sa pagpapatakbo | 488.90M | 10.66% |
Net na kita | 283.80M | 110.85% |
Net profit margin | 23.47 | 73.34% |
Kita sa bawat share | 0.61 | 35.56% |
EBITDA | 306.10M | 47.66% |
Aktuwal na % ng binabayarang buwis | 19.44% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.32B | 33.29% |
Kabuuang asset | 7.50B | 18.04% |
Kabuuang sagutin | 4.77B | 9.12% |
Kabuuang equity | 2.73B | — |
Natitirang share | 390.02M | — |
Presyo para makapag-book | 8.02 | — |
Return on assets | 8.18% | — |
Return on capital | 11.60% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 283.80M | 110.85% |
Cash mula sa mga operasyon | 659.90M | 230.78% |
Cash mula sa pag-invest | 192.80M | -8.32% |
Cash mula sa financing | -175.00M | 76.24% |
Net change in cash | 676.60M | 312.70% |
Malayang cash flow | 406.62M | 740.79% |
Tungkol
Dexcom, Inc. is an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland. Wikipedia
Itinatag
1999
Headquarters
Website
Mga Empleyado
10,250
